Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nuclear Proteins | 29 | 2025 | 740 | 6.390 |
Why?
|
| Membrane Proteins | 23 | 2025 | 1264 | 5.400 |
Why?
|
| Muscular Dystrophy, Emery-Dreifuss | 13 | 2025 | 16 | 3.930 |
Why?
|
| Muscle Development | 6 | 2025 | 39 | 3.660 |
Why?
|
| Nuclear Envelope | 15 | 2025 | 36 | 3.060 |
Why?
|
| Cell Nucleus | 17 | 2024 | 603 | 2.110 |
Why?
|
| Cell Differentiation | 8 | 2025 | 1621 | 1.990 |
Why?
|
| Histone Deacetylases | 3 | 2017 | 86 | 1.210 |
Why?
|
| Nuclear Matrix | 2 | 2021 | 3 | 1.180 |
Why?
|
| Cell Movement | 2 | 2024 | 809 | 1.180 |
Why?
|
| Myoblasts | 2 | 2020 | 33 | 0.980 |
Why?
|
| Stem Cells | 2 | 2020 | 387 | 0.950 |
Why?
|
| Transcription Factors | 7 | 2014 | 1691 | 0.820 |
Why?
|
| Lamin Type A | 5 | 2015 | 26 | 0.820 |
Why?
|
| Lipids | 1 | 2025 | 278 | 0.810 |
Why?
|
| Nanoparticles | 1 | 2025 | 198 | 0.790 |
Why?
|
| Muscle, Skeletal | 5 | 2020 | 474 | 0.770 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 572 | 0.750 |
Why?
|
| MyoD Protein | 2 | 2013 | 16 | 0.750 |
Why?
|
| Nuclear Lamina | 2 | 2013 | 7 | 0.700 |
Why?
|
| LIM Domain Proteins | 4 | 2014 | 24 | 0.690 |
Why?
|
| Dystroglycans | 1 | 2020 | 15 | 0.660 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 45 | 0.630 |
Why?
|
| RNA, Messenger | 3 | 2025 | 2026 | 0.620 |
Why?
|
| Thiazoles | 1 | 2020 | 124 | 0.610 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 3110 | 0.580 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2013 | 392 | 0.580 |
Why?
|
| Animals | 24 | 2025 | 28155 | 0.580 |
Why?
|
| Mice | 16 | 2025 | 12269 | 0.570 |
Why?
|
| Mutation | 7 | 2021 | 4272 | 0.560 |
Why?
|
| Protein Binding | 13 | 2021 | 1534 | 0.550 |
Why?
|
| Active Transport, Cell Nucleus | 7 | 2020 | 79 | 0.500 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 200 | 0.470 |
Why?
|
| Thymopoietins | 6 | 2005 | 6 | 0.470 |
Why?
|
| HeLa Cells | 10 | 2020 | 517 | 0.460 |
Why?
|
| Homeodomain Proteins | 2 | 2011 | 556 | 0.450 |
Why?
|
| PAX7 Transcription Factor | 1 | 2013 | 4 | 0.410 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2013 | 3 | 0.410 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2850 | 0.410 |
Why?
|
| Cell Line | 5 | 2021 | 2464 | 0.390 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2013 | 665 | 0.380 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2001 | 123 | 0.380 |
Why?
|
| Myoblasts, Skeletal | 1 | 2012 | 4 | 0.370 |
Why?
|
| DNA-Binding Proteins | 5 | 2023 | 1234 | 0.370 |
Why?
|
| Ribonucleoproteins | 3 | 2002 | 36 | 0.370 |
Why?
|
| Calcium-Binding Proteins | 3 | 2002 | 119 | 0.350 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 50 | 0.340 |
Why?
|
| Humans | 31 | 2025 | 93515 | 0.330 |
Why?
|
| Carrier Proteins | 7 | 2002 | 663 | 0.320 |
Why?
|
| Signal Transduction | 7 | 2025 | 3502 | 0.320 |
Why?
|
| Binding Sites | 7 | 2020 | 1133 | 0.310 |
Why?
|
| Nuclear Matrix-Associated Proteins | 3 | 2016 | 15 | 0.300 |
Why?
|
| Gene Expression Regulation | 5 | 2014 | 1985 | 0.290 |
Why?
|
| Transcription, Genetic | 5 | 2011 | 1117 | 0.290 |
Why?
|
| Cardiomyopathies | 2 | 2009 | 291 | 0.280 |
Why?
|
| Muscular Dystrophies | 4 | 2012 | 54 | 0.270 |
Why?
|
| MicroRNAs | 1 | 2012 | 580 | 0.260 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 82 | 0.260 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 1061 | 0.260 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 106 | 0.250 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2002 | 144 | 0.250 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 282 | 0.250 |
Why?
|
| Neoplasms | 1 | 2021 | 3169 | 0.240 |
Why?
|
| Proteome | 1 | 2007 | 153 | 0.240 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1741 | 0.240 |
Why?
|
| Myocardium | 2 | 2008 | 570 | 0.230 |
Why?
|
| Karyopherins | 3 | 2001 | 15 | 0.230 |
Why?
|
| Liposomes | 1 | 2025 | 98 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2007 | 304 | 0.220 |
Why?
|
| Lamins | 3 | 2008 | 6 | 0.220 |
Why?
|
| Actins | 2 | 2005 | 467 | 0.220 |
Why?
|
| Phenotype | 3 | 2024 | 2544 | 0.210 |
Why?
|
| MCF-7 Cells | 1 | 2024 | 120 | 0.210 |
Why?
|
| Chromatin | 3 | 2013 | 440 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 1 | 2024 | 254 | 0.200 |
Why?
|
| Mice, Knockout | 3 | 2020 | 2121 | 0.200 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 502 | 0.200 |
Why?
|
| Genome, Human | 1 | 2008 | 823 | 0.200 |
Why?
|
| Actin Cytoskeleton | 1 | 2004 | 196 | 0.190 |
Why?
|
| Histones | 2 | 2017 | 361 | 0.190 |
Why?
|
| Cytosol | 2 | 2001 | 193 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2020 | 3435 | 0.170 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 290 | 0.170 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 521 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 309 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2021 | 371 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2755 | 0.150 |
Why?
|
| Mice, Nude | 1 | 2021 | 824 | 0.150 |
Why?
|
| Cell Cycle | 1 | 2021 | 515 | 0.150 |
Why?
|
| Regeneration | 1 | 2020 | 159 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 1338 | 0.150 |
Why?
|
| RNA-Binding Proteins | 3 | 2015 | 306 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 7 | 2008 | 729 | 0.140 |
Why?
|
| ran GTP-Binding Protein | 4 | 2002 | 4 | 0.140 |
Why?
|
| Cytoplasm | 3 | 2011 | 278 | 0.130 |
Why?
|
| Calcium | 1 | 2002 | 1176 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2013 | 298 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2014 | 2495 | 0.130 |
Why?
|
| Butadienes | 1 | 2017 | 33 | 0.130 |
Why?
|
| Theophylline | 1 | 2017 | 34 | 0.130 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2017 | 53 | 0.130 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 3 | 2001 | 14 | 0.120 |
Why?
|
| Myosin Heavy Chains | 1 | 2017 | 86 | 0.120 |
Why?
|
| Acetylation | 1 | 2017 | 149 | 0.120 |
Why?
|
| Flavonoids | 1 | 2017 | 85 | 0.120 |
Why?
|
| Organ Specificity | 2 | 2008 | 279 | 0.120 |
Why?
|
| Nitriles | 1 | 2017 | 154 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2013 | 443 | 0.120 |
Why?
|
| Imidazoles | 1 | 2017 | 138 | 0.120 |
Why?
|
| Chromatography, Affinity | 2 | 2007 | 83 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2017 | 107 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 701 | 0.120 |
Why?
|
| Kinetics | 2 | 2012 | 1492 | 0.120 |
Why?
|
| Pyridines | 1 | 2017 | 303 | 0.110 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2014 | 3 | 0.110 |
Why?
|
| Muscular Diseases | 1 | 2015 | 67 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 555 | 0.110 |
Why?
|
| Models, Biological | 2 | 2017 | 1768 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2017 | 1133 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 216 | 0.100 |
Why?
|
| Muscle Contraction | 1 | 2014 | 256 | 0.100 |
Why?
|
| Calreticulin | 3 | 2002 | 16 | 0.100 |
Why?
|
| Body Weight | 1 | 2014 | 449 | 0.100 |
Why?
|
| Muscle Proteins | 1 | 2013 | 129 | 0.100 |
Why?
|
| Echocardiography | 2 | 2014 | 745 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 603 | 0.090 |
Why?
|
| Cell Membrane | 2 | 2006 | 664 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2014 | 257 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 88 | 0.090 |
Why?
|
| Cell Membrane Permeability | 3 | 2002 | 121 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2013 | 260 | 0.090 |
Why?
|
| Morpholines | 1 | 2012 | 61 | 0.090 |
Why?
|
| beta Catenin | 1 | 2013 | 265 | 0.090 |
Why?
|
| Catalysis | 1 | 2012 | 216 | 0.090 |
Why?
|
| PAX3 Transcription Factor | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2011 | 83 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2014 | 811 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2012 | 674 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 308 | 0.080 |
Why?
|
| Female | 3 | 2024 | 48702 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 317 | 0.080 |
Why?
|
| Down-Regulation | 1 | 2011 | 524 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 407 | 0.070 |
Why?
|
| Aging, Premature | 1 | 2008 | 6 | 0.070 |
Why?
|
| Atrioventricular Node | 1 | 2008 | 38 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 177 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 962 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2012 | 555 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2007 | 31 | 0.070 |
Why?
|
| Chromatography, Gel | 1 | 2007 | 100 | 0.070 |
Why?
|
| Syndrome | 1 | 2008 | 437 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2002 | 404 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 136 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 2008 | 2910 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2004 | 2012 | 0.060 |
Why?
|
| Mutation, Missense | 2 | 2009 | 297 | 0.060 |
Why?
|
| Protein Interaction Mapping | 1 | 2006 | 78 | 0.060 |
Why?
|
| DNA | 2 | 2002 | 1265 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1518 | 0.060 |
Why?
|
| Precipitin Tests | 2 | 2003 | 108 | 0.060 |
Why?
|
| Nuclear Pore | 2 | 2002 | 12 | 0.060 |
Why?
|
| Nuclear Localization Signals | 2 | 2002 | 10 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 192 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 376 | 0.060 |
Why?
|
| Protein Transport | 1 | 2006 | 438 | 0.060 |
Why?
|
| Gelsolin | 1 | 2004 | 11 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 2002 | 363 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 691 | 0.050 |
Why?
|
| Apoptosis | 2 | 2008 | 1721 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 4 | 2004 | 55 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2002 | 141 | 0.050 |
Why?
|
| Digoxin | 1 | 2002 | 21 | 0.050 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2002 | 69 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 291 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2002 | 37 | 0.050 |
Why?
|
| Cytoskeletal Proteins | 3 | 2009 | 223 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2001 | 58 | 0.040 |
Why?
|
| Biological Assay | 1 | 2002 | 82 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2002 | 101 | 0.040 |
Why?
|
| Plants | 1 | 2002 | 118 | 0.040 |
Why?
|
| Biological Transport | 2 | 1999 | 404 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2001 | 27 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 887 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 260 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2001 | 111 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2002 | 299 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 1914 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2015 | 43 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2003 | 275 | 0.020 |
Why?
|
| DNA, Complementary | 2 | 2003 | 384 | 0.020 |
Why?
|
| Heterochromatin | 1 | 2009 | 26 | 0.020 |
Why?
|
| Laminin | 1 | 2009 | 91 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2009 | 313 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 756 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 61 | 0.010 |
Why?
|
| RNA Splicing Factors | 1 | 2003 | 30 | 0.010 |
Why?
|
| Time Factors | 2 | 2003 | 5410 | 0.010 |
Why?
|
| Gene Library | 1 | 2003 | 126 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2003 | 113 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 88 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 110 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 148 | 0.010 |
Why?
|
| Streptavidin | 1 | 2002 | 14 | 0.010 |
Why?
|
| RNA Splicing | 1 | 2003 | 157 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 948 | 0.010 |
Why?
|
| COS Cells | 1 | 2001 | 164 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2001 | 36 | 0.010 |
Why?
|
| Saccharomyces | 1 | 2001 | 22 | 0.010 |
Why?
|
| Gene Products, rev | 1 | 2001 | 1 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 164 | 0.010 |
Why?
|
| RNA, Small Nuclear | 1 | 2001 | 36 | 0.010 |
Why?
|
| GTPase-Activating Proteins | 1 | 2001 | 68 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2001 | 192 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2002 | 470 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 257 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 460 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 573 | 0.010 |
Why?
|
| RNA, Transfer | 1 | 2001 | 168 | 0.010 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 1999 | 121 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 1999 | 245 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 2220 | 0.010 |
Why?
|
| Male | 1 | 2008 | 44557 | 0.000 |
Why?
|